Levin Arthur A insider trades
Levin Arthur A has filed 39 Form 4s with the SEC that we hold, for RNAM (Director) and Stoke Therapeutics, Inc. (STOK) (Director). Across all of them we count 0 purchases worth $0 and 28 sales worth $15.7M reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($149.6K). The largest single trade was a sale of 107,500 shares of RNA worth $5.1M, dated 2025-08-06. The first filing on our record is dated 2021-11-22 and the latest 2026-06-05.
RNAM
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-11-18 | S, sale reported on Form 4 | 25,000 | $697.2K | 2021-11-22 |
| 2022-08-12 | S, sale reported on Form 4 | 14,003 | $308.1K | 2022-08-31 |
| 2022-08-15 | S, sale reported on Form 4 | 62,498 | $1.4M | 2022-08-31 |
| 2022-08-16 | S, sale reported on Form 4 | 3,499 | $77.3K | 2022-08-31 |
| 2022-12-29 | S, sale reported on Form 4 | 40,000 | $880.4K | 2023-01-03 |
| 2023-01-12 | S, sale reported on Form 4 | 10,000 | $220.0K | 2023-01-17 |
| 2023-02-14 | S, sale reported on Form 4 | 523 | $12.7K | 2023-02-15 |
| 2023-02-14 | S, sale reported on Form 4 | 9,477 | $223.8K | 2023-02-15 |
| 2023-03-15 | S, sale reported on Form 4 | 100 | $2.2K | 2023-03-17 |
| 2024-01-22 | S, sale reported on Form 4 | 1,859 | $18.8K | 2024-01-23 |
| 2024-03-12 | S, sale reported on Form 4 | 2,641 | $58.1K | 2024-03-12 |
| 2024-03-12 | S, sale reported on Form 4 | 25,000 | $551.0K | 2024-03-12 |
| 2024-03-19 | S, sale reported on Form 4 | 5,000 | $119.8K | 2024-03-21 |
| 2024-04-03 | S, sale reported on Form 4 | 20,000 | $542.2K | 2024-04-03 |
| 2024-04-19 | S, sale reported on Form 4 | 5,000 | $114.1K | 2024-04-22 |
| 2024-05-20 | S, sale reported on Form 4 | 5,000 | $149.5K | 2024-05-21 |
| 2024-06-12 | S, sale reported on Form 4 | 40,000 | $1.4M | 2024-06-14 |
| 2024-06-13 | S, sale reported on Form 4 | 60,000 | $2.4M | 2024-06-14 |
| 2024-06-20 | S, sale reported on Form 4 | 5,000 | $188.0K | 2024-06-21 |
| 2024-07-19 | S, sale reported on Form 4 | 5,000 | $225.1K | 2024-07-23 |
| 2024-08-19 | S, sale reported on Form 4 | 5,000 | $225.9K | 2024-08-21 |
| 2024-09-19 | S, sale reported on Form 4 | 5,000 | $228.6K | 2024-09-20 |
| 2024-10-21 | S, sale reported on Form 4 | 5,000 | $233.2K | 2024-10-23 |
| 2024-11-19 | S, sale reported on Form 4 | 3,323 | $140.0K | 2024-11-20 |
| 2025-01-21 | S, sale reported on Form 4 | 1,872 | $53.5K | 2025-01-23 |
| 2025-08-06 | S, sale reported on Form 4 | 107,500 | $5.1M | 2025-08-08 |
| 2026-01-21 | S, sale reported on Form 4 | 1,758 | $127.4K | 2026-01-23 |
Stoke Therapeutics, Inc. (STOK)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-03-13 | S, sale reported on Form 4 | 605 | $22.3K | 2026-03-17 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1181556) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms